NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
2021; National Comprehensive Cancer; Volume: 19; Issue: 3 Linguagem: Inglês
10.6004/jnccn.2021.0013
ISSN1540-1413
AutoresDavid S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes,
Tópico(s)Lung Cancer Diagnosis and Treatment
ResumoThe NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
Referência(s)